Browsing by Author "Büyükaşık, Yahya"
Now showing items 1-3 of 3
-
Determining the frequency of iron overload at diagnosis in de novo acute myeloid leukemia patients with multilineage dysplasia or myelodysplasia-related changes: a case control study
Yavuz, Boran; Aydın, Seda; Bozkurt, Sureyya; Üner, Ayşegül; Büyükaşık, Yahya (Springer Heidelberg, 2019)Acute myeloid leukemia (AML) with myelodysplasia-related changes (AML-MRC) is a new disease category, which was defined as a separate entity in the World Health Organization Classification of Tumours of Haematopoietic and ... -
Downregulation of stearoyl-CoA desaturase 1 (SCD-1) promotes resistance to imatinib in chronic myeloid leukemia
Günes, Buket Altınok; Hekmatshoar, Yalda; Özkan, Tülin; Bozkurt, Süreyya; Aydos, Oya Sena Erdoğan; Büyükaşık, Yahya; Aladağ, Elifcan; Asuman Sunguroğlu (Mattioli 1885, 2022)Chronic myeloid leukemia (CML) is a malignant hematopoietic stem cell disease resulting in the fusion of BCR and ABL genes and characterized by the presence of the reciprocal translocation t(9;22)(q34;q11). BCR-ABL, a ... -
Real life experience regarding clinical characteristics and treatment outcome in non-cutaneous peripheral t cell lymphomas: A multicenter study of Turkish hematology research and education group (threg)
Kayıkçı, Ömür; Özgür, Mehtap; Sarı, İsmail; Demirkan, Fatih; Beyan, Cengiz; Güven, Çetin; Vural, Filiz; Yılmaz, Mehmet; Öztürk, Erman; Akpınar, Seval; Eser, Bülent; Gündüz, Mehmet; Büyükaşık, Yahya; Payzın, Bahriye; Yıldırım, Rahşan; Doğu, Mehmet Hilmi; Özkan, Atilla; Kelkitli, Engin; Tekgündüz, Emre (Gelanos, 2022)Objective: Peripheral T-NK-cell lymphomas (PTCL) are uncommon, quite heterogeneous group of disorders, and representing only 10–15% of all non-Hodgkin lymphomas (NHL). Although both molecular and clinical studies have ...
